Combined Use of Anticancer Drugs and an Inhibitor of Multiple Drug Resistance-Associated Protein-1 Increases Sensitivity and Decreases Survival of Glioblastoma Multiforme Cells In Vitro

Cancer Statistics, 2010

Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu et al. · CA A Cancer Journal for Clinicians · 2010 · 12.6K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

W.K. Alfred Yung, Robert E. Albright, Jeffrey J. Olson et al. · British Journal of Cancer · 2000 · 939 citations · Full text

Medicine, Oncology, Pharmacology +17

Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Temozolomide in Malignant Glioma Patients

Sandrine Ostermann, Chantal Csajka, Thierry Buclin et al. · Clinical Cancer Research · 2004 · 513 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal.

Cheol-Hee Choi · Cancer Cell International · 2005 · 512 citations · Full text

Medicine, Oncology, Pharmacology +17

The Leukotriene LTD4 Receptor Antagonist Mk571 Specifically Modulates MRP Associated Multidrug Resistance

Volker Gekeler, W Ise, Karl H. Sanders et al. · Biochemical and Biophysical Research Communications · 1995 · 406 citations

Medicine, Pharmacokinetics, Pharmacology +8